- 英文名称
- N-(4-Oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide
- 分子式
- C11H14N4O2
- 分子量
- 234.25
- 中文别名
- N-(4-氧代-4,7-二氢-1H-吡咯并[2,3-D]嘧啶-2-基)新戊酰胺; N-(4-羟基-7H-吡咯并[2,3-D]嘧啶-2-基)特戊酰胺; N-(4-氧代-4,7-二氢-3H-吡咯并[2,3-D]嘧啶-2-基)-2,2-二甲基丙酰胺; Propanamide, N-(4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethyl-; N-(4,7-Dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropanamide; N-(4-Hydroxy-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropionamide; 2-(2,2-二甲基丙酰基)氨基-4-羟基吡咯并[2,3-d]嘧啶; N-(4-hydroxy-1H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide; N-(4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide; 2,2-dimethyl-N-(4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-2-yl)propanamide; N-(4,7-Dihydro-4-Oxo-3H-Pyrrolo[2,3-d]Pyrimidin-2-Yl)-2,2-Dimethyl-Propanamide; 2,2-dimethyl-N-(4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)-propionamide
- 用途
- 作为医药中间体，用于合成相关药物分子，通过降低极性和提高溶解度优化反应过程。
